/
FLNA
$0.75-$0.01 (-1.77%)live
Change$-1.41
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$33.1M
48M shares
52-week range
$0.67 – $2.27
5% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Filana Therapeutics, Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
www.filanatx.com- Employees
- 20
- IPO / List date
- Jul 14, 2000
- HQ
- AUSTIN, TX
Held by traders on TradeandTell
No one on the platform currently holds FLNA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 326,759 | $552.2K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2005-06-20 | 10-for-1 |
Recent trades on TradeandTell
No one on the platform has traded FLNA yet.
